Related Experiment Video

Updated: Aug 19, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Somatostatin, somatostatin receptors, and pancreatic cancer

Min Li1, William E Fisher, Hee Joon Kim

  • 1Elkins Pancreas Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine and the Methodist Hospital, 6550 Fannin Street, Houston, Texas 77030, USA. minli@bcm.tmc

World Journal of Surgery
|February 12, 2005
PubMed

Insights

Somatostatin receptors (SSTRs) regulate cancer growth. Reintroducing SSTR genes inhibits pancreatic cancer, suggesting their therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Somatostatin and its receptors (SSTRs) are implicated in regulating cancer progression.
  • Pancreatic cancer growth may be influenced by interactions with cell surface SSTRs.

Purpose of the Study:

  • To review the function of five cloned somatostatin receptors (SSTRs).
  • To explore the role of SSTRs in pancreatic cancer growth and potential therapeutic strategies.

Main Methods:

  • Review of existing literature on somatostatin receptors and pancreatic cancer.
  • Analysis of the roles of individual SSTR subtypes (SSTR-1, SSTR-2, SSTR-3, SSTR-4, SSTR-5) in cancer biology.

Main Results:

  • SSTR-1, SSTR-2, and SSTR-5 are key in inhibiting pancreatic cancer growth in vitro and in vivo.
  • SSTR-3 may induce apoptosis, while SSTR-4's role remains unclear.
  • Functional SSTRs are frequently absent in pancreatic tumors.

Conclusions:

  • Restoring SSTR gene function can inhibit pancreatic cancer growth.
  • SSTRs represent a potential therapeutic target for pancreatic cancer treatment.

More Related Videos

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...